Edition:
United States

People: Dr.Reddy's Laboratories Ltd (RDY.N)

RDY.N on New York Stock Exchange

47.26USD
8 Dec 2016
Change (% chg)

$0.93 (+2.01%)
Prev Close
$46.33
Open
$47.14
Day's High
$47.75
Day's Low
$46.75
Volume
64,628
Avg. Vol
56,232
52-wk High
$54.70
52-wk Low
$40.74

Reddy, Cartikeya 

Dr. Cartikeya Reddy is Senior Vice President, Head - Biologics of Dr. Reddy's Laboratories Ltd since 2012. He focuses on the development of biosimilar molecules for the Indian and global markets. Prior to joining in 2004, Mr. Reddy worked with Genentech Inc., where he was a Group Leader in the area of Cell Culture Process Development. Before that, he was with the Biotechnology Division of Bayer Corporation, where he led teams in the areas of Bioprocess Development and pilot scale manufacturing. Mr. Reddy holds a Master of Science degree and Ph.D. in Chemical Engineering from the University of Illinois, Urbana-Champaign, and was a Visiting Scholar at the Massachusetts Institute of Technology in Cambridge, Massachusetts, United States of America. He also graduated with a Bachelor of Technology degree in Chemical Engineering from the Indian Institute of Technology in Chennai, India.

Basic Compensation

Total Annual Compensation, INR --
Restricted Stock Awards, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 8,800,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Satish Reddy

114,639

G. Prasad

109,464,000

Saumen Chakraborty

15,000,000

Sripada Chandrasekhar

--

Abhijit Mukherjee

14,600,000

Amit Biswas

--
As Of  30 Mar 2014